Bloorian

LIFESTYLE

Latest news and updates

EPILEPSY CARE IS BROKEN. HERE IS HOW TO FIX IT.

EPILEPSY CARE IS BROKEN. HERE IS HOW TO FIX IT.

The system treating epilepsy hasn't kept up with the science. Patients are paying the price.

MedBary TeamJun 21, 2026
Skin Deep: The Science of Lasting Radiance

Skin Deep: The Science of Lasting Radiance

Your skin is keeping score. Every habit, every hour of sleep, every meal — it's all in there.

MedBary TeamJun 18, 2026
Stop Eating for Muscles You Aren't Building

Stop Eating for Muscles You Aren't Building

Beef or lentils, whey or whole foods — the source matters less than you think. So does the quantity.

MedBary TeamJun 17, 2026
You're Not Diabetic Yet — And That's Everything

You're Not Diabetic Yet — And That's Everything

Somewhere between normal and diabetic lives a window — and it's still open.

MedBary TeamJun 17, 2026
The Quiet Erosion: Inside Vascular Dementia

The Quiet Erosion: Inside Vascular Dementia

Unlike Alzheimer's, vascular dementia doesn't need protein deposits to destroy a mind — it just needs to cut off the blood supply. And it's far more common than most people realize

MedBary TeamJun 16, 2026
The Bargain We Make With the Sun

The Bargain We Make With the Sun

For generations, we've bargained with the sun in silence, and paid the price in ways we're only beginning to understand. Dermatology is rewriting the terms.

MedBary TeamJun 16, 2026
Sleep & Obesity: The Vicious Cycle

Sleep & Obesity: The Vicious Cycle

How poor sleep drives weight gain and how excess weight destroys your sleep. Inside the bidirectional biology that most weight-loss advice ignores.

MedBary TeamJun 15, 2026
Can We Make Cells Young Again?

Can We Make Cells Young Again?

A landmark clinical trial has treated its first human participant with a cellular reprogramming therapy — injecting genes that instruct aged cells to behave as if they were young.

MedBary TeamJun 12, 2026
Apixaban vs Rivaroxaban: Rethinking the Default Choice in VTE Anticoagulation

Apixaban vs Rivaroxaban: Rethinking the Default Choice in VTE Anticoagulation

For years, apixaban and rivaroxaban have been treated as interchangeable workhorses of venous thromboembolism (VTE) management. Both are direct oral anticoagulants (DOACs), both ta

MedBary TeamJun 11, 2026
AI in Healthcare Is Moving From Experiment to Everyday Support

AI in Healthcare Is Moving From Experiment to Everyday Support

Artificial intelligence is rapidly becoming part of modern healthcare, supporting doctors with faster insights, smarter patient monitoring, and more efficient clinical workflows. B

MedBary TeamJun 11, 2026
PreviousPage 7 of 8Next